CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $50.90 $54.34 (+1.30%) +5.68% -0.34% +6.02
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $0.22 (+1.86%) -86.46% -0.34% -86.12
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $0.55 (+4.95%) -72.65% -0.34% -72.30
17/03/2014 GDXJ.US 4 out of 5 Outperform 5Y $43.69 $24.18 (+0.71%) -45.20% -0.34% -44.86
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $33.63 $35.54 (+0.59%) +5.09% -0.34% +5.43
17/03/2014 ANVGQ.US 2 out of 5 Outperform 5Y $6.37 $0.04 (0%) -99.39% -0.34% -99.04
17/03/2014 GG.US 4 out of 5 Outperform 5Y $27.18 $15.28 (+1.87%) -44.58% -0.34% -44.23
29/02/2012 16/03/2014 AMZN.US 4 out of 5 Underperform 3Y $179.70 $510.46 (+1.32%) +185.61% +34.67% -150.94
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $1.70 (+1.19%) -72.62% +23.53% -96.16
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $3.58 (+4.07%) -21.03% +21.89% -42.92
11/02/2013 PAAS.US 4 out of 5 Outperform 5Y $15.66 $8.75 (+0.92%) -44.56% +21.89% -66.45
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $4.68 (+4.23%) +46.16% +23.01% +23.14
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.61 (+3.95%) -86.59% +23.01% -109.61
04/02/2013 SSRI.US 4 out of 5 Outperform 5Y $12.09 $5.97 (+1.70%) -51.20% +23.04% -74.24
04/02/2013 GORO.US 2 out of 5 Outperform 5Y $10.91 $1.72 (+0.58%) -84.42% +23.04% -107.46
24/01/2013 SGSVF.US 3 out of 5 Outperform 5Y $2.51 $0.55 (-1.18%) -77.96% +24.00% -101.97
23/01/2013 NRT.US 3 out of 5 Outperform 1Y $18.71 $8.25 (-0.36%) -56.32% +24.02% -80.34
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $6.28 (+2.61%) +18.39% +24.02% -5.63
23/01/2013 POT.US 4 out of 5 Outperform 5Y $36.06 $15.39 (-1.66%) -57.35% +24.02% -81.37
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $2.33 (+2.64%) -78.17% +25.91% -104.08
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.